MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
出版年份 2018 全文链接
标题
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
作者
关键词
Lung cancer, Neo-antigen, Cancer vaccine, PD1 checkpoint blocking antibody
出版物
BMC GENOMICS
Volume 19, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-03
DOI
10.1186/s12864-018-4958-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma
- (2017) Julie S. Nielsen et al. OncoImmunology
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens
- (2015) Anna Polyakova et al. Expert Review of Proteomics
- Modeling the Specific CD4+T Cell Response against a Tumor Neoantigen
- (2015) Héloïse Flament et al. JOURNAL OF IMMUNOLOGY
- Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer
- (2015) Johnathan D. Ebben et al. MOLECULAR CARCINOGENESIS
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Pancreatic cancer, treatment options, and GI-4000
- (2015) Marion L Hartley et al. Human Vaccines & Immunotherapeutics
- AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data
- (2014) Lei Bao et al. BIOINFORMATICS
- Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
- (2014) Jamie E. Chaft et al. Clinical Lung Cancer
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
- (2014) Priscilla K Brastianos et al. NATURE GENETICS
- High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
- (2014) Marit M van Buuren et al. OncoImmunology
- Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry
- (2013) Loren Gragert et al. HUMAN IMMUNOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- EGF receptor variant III as a target antigen for tumor immunotherapy
- (2008) Gordon Li et al. Expert Review of Vaccines
- NetMHCpan, a method for MHC class I binding prediction beyond humans
- (2008) Ilka Hoof et al. IMMUNOGENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now